References
1. HIV/AIDS July 17, 2021 Key facts (accessed March 14, 2022). Report for World AIDS Day. Geneva: Joint United Nations Program on HIV/AIDS (UNAIDS)б 2021. Global Health Sector Strategy to End HIV 2016–2021 Towards End AIDS. URL: https://apps.who.int/iris/bitstream/handle/10665/255763/WHO-HIV-2016.05-rus.pdf;sequence.
2. Ladnaya N.N., Sokolova E.V., Pokrovsky V.V. The main trends in the development of the HIV epidemic among women in the Russian Federation in 2021. In: International Scientific and Practical Conference «Current Issues of HIV Infection «Maternal and Child Health». Proceedings of the conference. Saint Petersburg: Chelovek i ego zdorov’e, 2022: 5–12. (in Russian)
3. Shcherbakova E.M. HIV epidemic: assessments and trends, 2018. In: Demoskop Weekly. 2018. No. 793–794. URL: http://demoscope.ru/weekly/2018/0793/barom01.php (in Russian)
4. Woman, child and HIV. In: N.A. Belyakov, N.Yu. Rakhmanova, A.G. Rakhmanova. Saint Petersburg: Baltiyskiy meditsinskiy obrazovatel’niy tsentr, 2012: 600 p. (in Russian)
5. Kozyrina N.V., Ladnaya N.N., Shakhgil’dyan V.I., Ivanova L.A., Narsiya R.S., Dement’eva L.A. Prevention of the vertical route of HIV transmission and the problem of perinatal mortality in children born to women with HIV. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy [Epidemiology and Infectious Diseases. Actual Issues]. 2020; 10 (3): 79–86. (in Russian)
6. Taylor M., Newman L., Ishikawa N., Laverty M., Hayashi C., Ghidinelli M., et al. Elimination of mother-to-child transmission of HIV and syphilis (EMTCT): process, progress, and program integration. PLoS Med. 2017; 14 (6): 329–38.
7. Joint United Nations Programme on HIV/AIDS (UNAIDS) Global HIV and AIDS Statistics/AVERT. 2019. URL: https://www.unaids.org/en/resources/fact-sheet
8. Kozyrina N.V., Ladnaya N.N., Narsiya R.S. Ways of elimination of vertical transmission of HIV infection. Zhurnal mikrobiologii, epidemiologii i immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2018; (6): 18–25. DOI: https://doi.org/10.36233/0372-9311-2018-6-18-25 (in Russian)
9. Koay W.L.A., Zhang J., Manepalli K.V., Griffith C.J., Castel A.D., Scott R.K., et al. Prevention of perinatal HIV transmission in an area of high HIV prevalence in the United States. J Pediatr. 2021; 228: 101–9. DOI: https://doi.org/10.1016/j.jpeds.2020.09.041
10. Yushchuk N.D., Maslyakov V.V., Aristanbekova M.S. Problems of prevention of perinatal transmission of HIV. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2019; 8 (1): 47–51. DOI: https://doi.org/10.24411/2305-3496-2019-11006 (in Russian)
11. Kassie D.G., Bogale W.A., Addisu A. The prevalence of HIV-positive infants born to HIV-positive mothers attended at the University of Gondar specialized hospital anti-retroviral therapy services, Northwest Ethiopia, 2018. HIV AIDS (Auckl). 2020; 26 (12): 135–40. DOI: https://doi.org/10.2147/HIV.S238315
12. UNAIDS. Global HIV & AIDS Statistics-2020 – Fact Sheet. Geneva: UNAIDS, 2020.
13. Carlucci J.G., Yu Z., González P., Bravo M., Amorim G., das Felicidades Cugara C., et al. The effect of a Mentor Mothers program on prevention of vertical transmission of HIV outcomes in Zambézia Province, Mozambique: a retrospective interrupted time series analysis. J Int AIDS Soc. 2022; 25 (6): e25952. DOI: https://doi.org/10.1002/jia2.25952
14. Katusiime M.G., Van Zyl. G.U., Cotton M.F., Kearney M.F. HIV-1 persistence in children during suppressive ART. Viruses. 2021; 13 (6): 1134. DOI: https://doi.org/10.3390/v13061134
15. Shalekoff S., Gray G.E., Tiemessen C.T. Age-related changes in expression of CXCR4 and CCR5 on peripheral blood leukocytes from uninfected infants born to human immunodeficiency virus type 1-infected mothers. Clin Diagn Lab Immunol. 2004; 11: 229–34. DOI: https://doi.org/10.1128/CDLI.11.1.229-234.2004
16. Cotton M.F., Violari A., Otwombe K., Panchia R., Dobbels E., Rabie H., et al. Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet. 2013; 382: 1555–63. DOI: https://doi.org/10.1016/S0140-6736(13)61409-9
17. Wamalwa D., Njuguna I., Maleche-Obimbo E., Begnel E., Chebet D.J., Onyango J.A., et al. Cytomegalovirus viremia and clinical outcomes in Kenyan children diagnosed with human immunodeficiency virus (HIV) in hospital. Clin Infect Dis. 2022; 74 (7): 1237–46. DOI: https://doi.org/10.1093/cid/ciab604
18. Onyango D.O., Akelo V., van der Sande M.A.B., Ridzon R., Were J.A., Agaya J.A., et al. Causes of death in HIV-infected and HIV-uninfected children aged under-five years in western Kenya. AIDS. 2022; 36 (1): 59–68. DOI: https://doi.org/10.1097/QAD.0000000000003086
19. Taylor A.W., Blau D.M., Bassat Q., Onyango D., Kotloff K.L., Arifeen S.E., et al.; CHAMPS Consortium. Initial findings from a novel population-based child mortality surveillance approach: a descriptive study. Lancet Glob Health. 2020; 8 (7): 909–19. DOI: https://doi.org/10.1016/S2214-109X(20)30205-9
20. Moreira-Silva S.F., Zandonade E., Frauches D.O., Machado E.A., Lopes L.I., Duque L.L., et al. Comorbidities in children and adolescents with AIDS acquired by HIV vertical transmission in Vitória, Brazil. PLoS One. 2013; 8 (12): e82027. DOI: https://doi.org/10.1371/journal.pone.0082027
21. Abuogi L.L., Smith C., McFarland E.J. Retention of HIV-infected children in the first 12 months of anti-retroviral therapy and predictors of attrition in resource limited settings: a systematic review. PLoS One. 2016; 11 (6): e0156506. DOI: https://doi.org/10.1371/journal.pone.0156506
22. Rozenberg V.Ya., Plotnikova Yu.K., Voronin E.E. Analysis of mortality in patients with HIV infection on the example of a region with a high prevalence of infection. Epidemiologiya i vaktsinoprofilaktika [Epidemiology and Vaccine Prophylaxis]. 2018; 17 (1): 40–7. DOI: https://doi.org/10.31631/2073-3046-2018-17-1-40-47